The 19 billion-dollar startups to watch that are revolutionizing healthcare in 2019
These are the top-valued private biotech and healthcare companies in 2019, according to PitchBook.
Dispensed Business Insider weekly healthcare newsletter July 26
Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.
RBC: Gilead should buy Otezla from Celgene, aiding Bristol-Myers deal
Bristol-Myers Squibb and Celgene have agreed to divest a drug called Otezla to win regulatory approval for their $74 billion merger.
GlaxoSmithKline's Jack Bailey on value-based care experiments
Drug companies are getting paid based on how well their treatments work. That's more complicated than it sounds.
Bank of America eyes longevity and aging market size growth
As humans begin to live longer and more make it to 100, it's going lead to a $610 billion market by 2025, according to analysts at Bank of America.
uBiome's board tapped Milbank's George Canellos to run investigation
George Canellos, a partner at Milbank who serves as the global head of the firm's litigation and arbitration group, will run the investigation.
Merck developing implant to prevent and treat HIV long-term: MK-8591
Scientists have long hoped for implants that can treat or prevent HIV, replacing daily pill regimens. Merck may soon make that dream a reality.
Fidelity biotech fund manager Eirene Kontopoulos on career, investments
Biotech stocks are notoriously risky. Fidelity biotech fund manager Eirene Kontopoulos told us about her strategy for navigating that volatility.
Bill Gates is worried about gene editing worsening inequality. Now a top ethicist is raising new red flags.
An exciting new scientific technology has made it possible to tinker with the very DNA that makes us who we are, offering up fresh hope of new cures for difficult diseases.
Big Pharma has tried and failed to cure Alzheimer's more than 200 times. The latest $18 billion flop leaves scientists hunting for a new path forward.
Alzheimer's disease is among the top causes of death in the US, and the cost of caring for people with dementia is about $290 billion a year.
Popular tags
Latest News
All About BotBro: Unregulated Forex Scam Costs Investors Millions
WikiFXNCC Bank Review: Expanding Services Amid Regulatory Concerns
WikiFXRM4.8 Million Gigamax Scandal: Investors Still Waiting for Answers
WikiFXSpain Cracks Down on €20 Million Crypto Laundering Network Linked to Organized Crime
WikiFXSpain Ramps Up Crackdown on Investment Scams and Unregistered Platforms
WikiFXCoinbase Targeted in $20M Extortion Plot After Customer Data Breach
WikiFXFCA Secures Over £300,000 in Confiscation Orders Against Investment Fraudsters
WikiFXInternational Operation Shuts Down €3M Fake Trading Platform
WikiFXThe Forces That Move Markets & How to Read Them
WikiFXTrade Nation 2025 Review: Spreads, Platforms, FCA and ASIC Licenses
WikiFX